Infections: Clinical Trials

696 trials for Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

696 unknown. 696 Phase 3, 173 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3696Unknown 696
Phase 2173Unknown 173

Follow Infections: new trials by email Literature Review of Infections trials Research Report on Infections

Trials (filtered) newest first · largest first

All 696 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination
High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), control group - COVID-19
Phase 3UnknownWestVac Biopharma Co., Ltd.49502024-12-302024-07-25
Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial
Hyperbaric oxygen - Post-COVID-19 Syndrome, Post-COVID Syndrome
Phase 3UnknownErasmus Medical Center1202024-10-012024-02-28
Effectivity of Protein Purified Derivative Treatment for Anogenital Warts in HIV Patient
Injection of protein purified derivative - Anogenital Warts, HIV Infection
Phase 2 / Phase 3UnknownUniversitas Padjadjaran302024-09-152024-09-19
A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection
GR2001, HTIG - Tetanus
Phase 3UnknownGenrix (Shanghai) Biopharmaceutical Co., Ltd.5822024-09-032024-10-10
Prophylactic Antibiotic in Subtalar Fusion Surgery
Ceftriaxone 2000 mg - Surgical Site Infection
Phase 2 / Phase 3UnknownAssiut University1022024-09-012024-07-30
Model-informed Precision Dosing for Linezolid
Linezolid - Gram-Positive Bacterial Infections
Phase 3UnknownUniversity of Hamburg-Eppendorf282024-09-012024-06-06
The Role of Antibiotic Prophylaxis in Lowering Wound Infection Rates Post-Open Repair of Primary Elective Groin Hernias in High-Risk Patients
Cefazolin 1000 MG - Antibiotic Prophylaxis, Wound Infection
Phase 3UnknownUniversity of Aleppo2002024-08-012024-08-28
Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia
Tab. Trimethoprim-sulfamethoxazole, Tab. Clindamycin, Tab. Cephalexin, or Tab. Linezolid, IV Cloxacillin, IV Cefazolin, IV Vancomycin, or IV Ceftaroline - Staphylococcus Aureus Bacteremia
Phase 3UnknownClinical Research Centre, Malaysia2902024-06-282024-07-05
Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial Injury in Patients with Pneumonia.
TAD® 600 mg/4 mL powder and solvent for solution for injection, Saline solution 0.9% of sodium chloride - Pneumonia, Myocardial Injury
Phase 3UnknownBiomedica Foscama S.p.A. Industria Chimico-Farmaceutica1782024-06-252024-11-27
A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects
Levamisole 3 days, Levamisole 5 days, Placebo - Loiasis
Phase 2 / Phase 3UnknownProgramme National de Lutte contre l'Onchocercose, Republic of the Congo992024-06-212024-09-20
Seasonal R21 Mass Vaccination for Malaria Elimination
R21Matrix M - Malaria
Phase 3UnknownLondon School of Hygiene and Tropical Medicine162002024-05-302024-08-29
Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection
Letermovir 480 MG, Ganciclovir - CMV Infection
Phase 3UnknownHospital do Rim e Hipertensão1002024-05-052024-04-02
Effect of PreforPro® on Urinary and Vaginal Health
Preforpro, Placebo - Bacterial Vaginosis, Bacterial Infections
Phase 3UnknownJeremy Burton502024-05-012024-01-09
Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma
Fecal microbiota transplant (Promicrobioma), Antibiotic - Clostridium Difficile Infections
Phase 3UnknownHospital Universitario Evangelico de Curitiba242024-05-012024-02-29
Metformin and Lactoferrin in Sepsis in Icu
Metformin, Lactoferrin - Sepsis
Phase 2 / Phase 3UnknownTanta University602024-04-012024-04-19
Effect of Metformin in Reducing Fatigue in Long COVID in Adolescents
Metformin, Placebo - Long COVID
Phase 3UnknownPurpose Life Sciences162024-04-012024-03-04
Effectiveness of a Single Dose of Betamethasone in Children With Symptomatic Adenovirus Infection
Bentelan, Placebo - Adenovirus
Phase 3UnknownA.O.U. Città della Salute e della Scienza802024-03-202024-03-21
Stellate Ganglion Block With Lidocaine for the Treatment of COVID-19-Induced Parosmia
Stellate Ganglion Block, Placebo - Parosmia
Phase 3UnknownLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's442024-02-152024-10-23
A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)
Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell), Recombinant COVID-19 Variant Vaccine (Sf9 Cell), Placebo - COVID-19
Phase 3UnknownWestVac Biopharma Co., Ltd.48002023-12-192024-04-23
Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder
Glecaprevir/pibrentasvir, Placebo - PTSD
Phase 2 / Phase 3UnknownWhite River Junction Veterans Affairs Medical Center922023-12-182025-04-24

Showing 20 of 696. Sign in to see all of them.

Narrower conditions

COVID-19 (235)  ·  HIV Infections (39)  ·  Sepsis (37)  ·  Coronavirus Infections (31)  ·  Hepatitis C (23)  ·  Pneumonia (20)  ·  Shock, Septic (19)  ·  Influenza, Human (17)  ·  Surgical Wound Infection (16)  ·  Hepatitis B, Chronic (15)  ·  Malaria (15)  ·  Hepatitis C, Chronic (14)  ·  Tuberculosis (14)  ·  Severe Acute Respiratory Syndrome (12)

Broader conditions

Virus Diseases (418)  ·  RNA Virus Infections (357)  ·  Respiratory Tract Diseases (312)  ·  Respiratory Tract Infections (296)  ·  Lung Diseases (276)  ·  Coronaviridae Infections (243)  ·  Nidovirales Infections (243)  ·  Pneumonia (243)  ·  Pneumonia, Viral (233)  ·  Coronavirus Infections (212)  ·  Pathological Conditions, Signs and Symptoms (192)  ·  Pathologic Processes (180)  ·  Bacterial Infections and Mycoses (109)  ·  Communicable Diseases (107)

Interventions

Standard of Care (21)  ·  Hydroxychloroquine (20)  ·  Ribavirin (17)  ·  Saline Solution (13)  ·  Dexamethasone (11)  ·  Ivermectin (11)  ·  Sofosbuvir (11)  ·  Ritonavir (10)  ·  Tenofovir (10)  ·  Lamivudine (9)  ·  favipiravir (9)  ·  peginterferon alfa-2a (9)  ·  Azithromycin (8)  ·  Isoniazid (8)  ·  Lopinavir (8)

Sponsors

Assistance Publique - Hôpitaux de Paris (12)  ·  Cairo University (10)  ·  London School of Hygiene and Tropical Medicine (10)  ·  Assiut University (9)  ·  Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (9)  ·  Mahidol University (8)  ·  Mansoura University (7)  ·  Ain Shams University (6)  ·  Chinese Academy of Medical Sciences (6)  ·  Makerere University (6)  ·  National Taiwan University Hospital (5)  ·  Tanta University (5)  ·  ANRS, Emerging Infectious Diseases (4)  ·  Aga Khan University (4)  ·  China National Biotec Group Company Limited (4)

Countries

China (83)  ·  United States (47)  ·  Egypt (39)  ·  Brazil (38)  ·  Italy (37)  ·  France (28)  ·  Spain (22)  ·  Indonesia (20)  ·  Canada (18)  ·  Russia (17)  ·  India (16)  ·  South Korea (16)  ·  Israel (15)  ·  Thailand (15)  ·  Mexico (14)

Top investigators

Adriano Lazzarin, MD (2)  ·  Bala Ambati (2)  ·  Cheng Yao (2)  ·  Chien-Chang Lee, MD, MSc (2)  ·  Dominicus Husada, MD (2)  ·  Fabio Ghezzi, M.D. (2)  ·  Hongxing Pan (2)  ·  Jvan Casarin, M.D. (2)  ·  Lin Du (2)  ·  Lloyd Tran, PhD (2)  ·  Nigel Hill, PhD (2)  ·  Sherief Abd-Elsalam, MD (2)  ·  Simone Garzon, M.D. (2)

Results publications

PMID 34473343, PMID 35244208, PMID 37489818, PMID 32171076, PMID 34350582, PMID 36695483, PMID 25030060, PMID 32109013, PMID 32142651, PMID 33240091, PMID 33502773, PMID 36700518, PMID 41972135, PMID 10816031, PMID 10925088, PMID 10990547, PMID 11063978, PMID 11176403, PMID 11197288, PMID 11238198, PMID 11500748, PMID 11594901, PMID 11723286, PMID 11857671, PMID 12244081, PMID 12777656, PMID 12807939, PMID 12894267, PMID 12949224, PMID 14677403, PMID 15023839, PMID 15147306, PMID 15214887, PMID 15232472, PMID 15269195, PMID 15288679, PMID 15351385, PMID 15616839, PMID 15897380, PMID 15987799, PMID 16002441, PMID 16211552, PMID 16287208, PMID 16441468, PMID 16794566, PMID 16973081, PMID 17121631, PMID 17264159, PMID 17359318, PMID 17385940

NIH funding

2015 (2), 2018 (2), 2019 (2), 2009 (1), 2014 (1), 2016 (1), K08HD052885 (1), P30CA138292 (1)